<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Radiation therapy combination &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/radiation-therapy-combination/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 06 Sep 2025 13:22:16 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Radiation therapy combination &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Revolutionary Treatment Strategy Reprograms Brain Cancer Cells to Curb Tumor Growth</title>
		<link>https://bioengineer.org/revolutionary-treatment-strategy-reprograms-brain-cancer-cells-to-curb-tumor-growth/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Wed, 26 Feb 2025 21:31:35 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[cancer cell reprogramming]]></category>
		<category><![CDATA[Forskolin research]]></category>
		<category><![CDATA[Glioblastoma treatment]]></category>
		<category><![CDATA[Radiation therapy combination]]></category>
		<category><![CDATA[Tumor growth suppression]]></category>
		<guid isPermaLink="false">https://bioengineer.org/revolutionary-treatment-strategy-reprograms-brain-cancer-cells-to-curb-tumor-growth/</guid>

					<description><![CDATA[UCLA scientists are embarking on a groundbreaking journey to revolutionize the treatment of glioblastoma, the most aggressive form of brain cancer known for its grim prognosis and high mortality rates. Their innovative strategy centers on the remarkable possibility of reprogramming aggressive cancer cells into benign, non-dividing cells, thereby diminishing the threat they pose to patients. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">237070</post-id>	</item>
	</channel>
</rss>
